Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in South Korea (KR) and operates extensively across Asia. Founded in 1963, the company has established itself as a leader in the development and manufacturing of a diverse range of healthcare products, including over-the-counter medications, herbal remedies, and nutritional supplements. Kwang Dong is renowned for its commitment to quality and innovation, with core products that cater to various health needs, setting them apart in a competitive market. The company has achieved significant milestones, including advancements in research and development, which have solidified its market position. With a focus on enhancing health and well-being, Kwang Dong continues to make notable contributions to the pharmaceutical landscape, earning recognition for its dedication to excellence and customer satisfaction.
DitchCarbon Score
How does Kwang Dong Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kwang Dong Pharmaceutical Co., Ltd.'s score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kwang Dong Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2019, Kwang Dong Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 30,160,000 kg CO2e across all scopes. This figure includes 1,569,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 28,591,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, the company did not disclose any Scope 3 emissions data for that year. Comparatively, in 2018, Kwang Dong's emissions were about 30,179,000 kg CO2e, with Scope 1 emissions at 1,006,000 kg CO2e and Scope 2 emissions at 30,179,000 kg CO2e. In 2017, the total emissions were approximately 31,106,000 kg CO2e, with Scope 1 emissions of 1,794,000 kg CO2e and Scope 2 emissions of 31,106,000 kg CO2e. Despite these figures, Kwang Dong Pharmaceutical has not set specific reduction targets or climate pledges, indicating a potential area for improvement in their climate commitments. The company operates within a sector that increasingly prioritises sustainability and carbon footprint reduction, highlighting the importance of establishing clear climate action goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | |
|---|---|---|---|
| Scope 1 | 1,794,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 31,106,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kwang Dong Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
